Cinryze Powder For Solution For Injection 500U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Cinryze: Powder for solution for injection (500U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

C1 INHIBITOR, HUMAN (C1 in HIB i ter, HYOO muhn) helps to prevent angioedema attacks.

In-Depth Information

Cinryze 500units Powder for Injection

NDC: 422270081
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Angioedema Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Hereditary Angioedema

Storage Information
Protect from light
Store in original container
Do not freeze
Reconstituted product should be used within 3 hours
Cinryze 500units Powder for Injection

Reported Side Effects for Cinryze 500units Powder for Injection

Infection Incidence:
1.8-3.5%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
2.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
3.0%*
Severity: MILD
Onset: RAPID
Flu Incidence:
3.5%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
3.5%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
3.5-10.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
4.7%*
Severity: MILD
Onset: EARLY
Fever Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
7.0-19.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
18.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cinryze

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5